{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:46:25Z","timestamp":1787010385513,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1,27]]},"DOI":"10.1097\/tp.0b013e3182a8607e","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T05:20:04Z","timestamp":1379654404000},"page":"220-226","source":"Crossref","is-referenced-by-count":22,"title":["Absence of Viable HCC in the Native Liver Is an Independent Protective Factor of Tumor Recurrence After Liver Transplantation"],"prefix":"10.1097","volume":"97","author":[{"given":"Roberto","family":"Montalti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Rompianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Di Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Cautero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ballarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"De Pietri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto I.","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio E.","family":"Gerunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210129","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/00004836-200211002-00002","article-title":"Hepatocellular carcinoma: an epidemiologic view.","volume":"35","author":"El-Serag","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R3-17-20210129","first-page":"352","article-title":"Epidemiology, risk factors and surveillance of hepatocellular carcinoma.","volume":"14","author":"Cabibbo","year":"2010","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R4-17-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.17.s2.8.x","article-title":"Review article: liver transplantation for HCC. Treatment options on the waiting list.","volume":"17","author":"Bolondi","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-17-20210129","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/j.1600-6143.2007.01863.x","article-title":"Treatment of HCC in patients awaiting liver transplantation.","volume":"7","author":"Schwartz","year":"2007","journal-title":"Am J Transplant"},{"key":"R6-17-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000315246","article-title":"Positioning and indication of sorafenib in the treatment algorithm and real practice setting: western and eastern approachAsian perspective.","volume":"78","author":"Lee","year":"2010","journal-title":"Oncology"},{"key":"R7-17-20210129","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1051-0443(07)61969-1","article-title":"Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology.","volume":"13","author":"Yamakado","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"R8-17-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1034\/j.1399-0012.2003.00062.x","article-title":"Radiofrequency ablation causes thermal fixation of hepatocellular carcinoma: a post-liver transplant histopathologic study.","volume":"17","author":"Coad","year":"2003","journal-title":"Clin Transplant"},{"key":"R9-17-20210129","first-page":"111","article-title":"Is advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy J Surg O","volume":"105","author":"Di Benedetto","year":"2012","journal-title":"ncol"},{"key":"R10-17-20210129","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/lt.20526","article-title":"A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.","volume":"11","author":"Yao","year":"2005","journal-title":"Liver Transpl"},{"key":"R11-17-20210129","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/01.TP.0000145892.97114.EE","article-title":"Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation.","volume":"78","author":"Ravaioli","year":"2004","journal-title":"Transplantation"},{"key":"R12-17-20210129","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1245\/s10434-011-1779-z","article-title":"Significance of tumor necrosis foroutcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation.","volume":"18","author":"Chan","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R13-17-20210129","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/1097-0142(19931215)72:12<3593::AID-CNCR2820721208>3.0.CO;2-T","article-title":"Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis.","volume":"72","author":"Adachi","year":"1993","journal-title":"Cancer"},{"key":"R14-17-20210129","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/lt.21033","article-title":"Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.","volume":"13","author":"Millonig","year":"2007","journal-title":"Liver Transpl"},{"key":"R15-17-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"R16-17-20210129","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/lt.22397","article-title":"Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy.","volume":"17","author":"Cucchetti","year":"2011","journal-title":"Liver Transpl"},{"key":"R17-17-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5009\/gnl.2009.3.4.285","article-title":"Prediction of complete necrosis ofhepatocellular carcinoma treated with transarterial chemoembolization prior to liver transplantation.","volume":"3","author":"Kim","year":"2009","journal-title":"Gut Liver"},{"key":"R18-17-20210129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"R19-17-20210129","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"R20-17-20210129","first-page":"307","article-title":"Receiver operating characteristic (ROC) methodology: the state of the art.","volume":"29","author":"Hanley","year":"1989","journal-title":"Crit Rev Diagn Imaging"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3182a8607e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:36:59Z","timestamp":1620963419000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201401270-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,27]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3182a8607e","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,27]]}}}